5th Annual Advances in Immuno-Oncology Congress

  • Check with publisher
  • Published date: November 12, 2019
  • Modified date: November 12, 2019
    • London, London, United Kingdom

Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools.

Over 60 presentations, case studies and panel discussions focused on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research.

PLUS, interactive opportunities including:
• Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
• 6 roundtable discussions on key industry growth areas within immuno-oncology

View Agenda: http://bit.ly/2NX4yWS

Day One – 21 May 2020
• Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
• Translational Immuno-Oncology
• Personalised Therapies for Immuno-Oncology

Day Two – 22 May 2020
• Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
• Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
• Clinical Research & Trials in Immuno- Oncology

Result 0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 6th Annual Next Generation Sequencing USA Congress

    6th Annual Next Generation Sequencing USA Congress

    Life Sciences Boston (Massachusetts) November 28, 2019 Check with publisher

    350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together ...

  • 7th Annual Peptides & Oligonucleotides Congress

    7th Annual Peptides & Oligonucleotides Congress

    Life Sciences London (United Kingdom) November 6, 2019 Check with publisher

    Over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. Over 40 case studies, presentations and panel discussions foc...

  • Recombinant Huaiyangshan Virus Nucleocapsid Protein (aa 1-252) [His]

    Recombinant Huaiyangshan Virus Nucleocapsid Protein (aa 1-252) [His]

    Life Sciences Shirley (New York) October 28, 2019 Check with publisher

    Huaiyangshan virus (HYSV) is a novel tick-borne bunyavirus. It causes haemorrhagic fever-like disease and has recently been reported in China. https://www.creative-biolabs.com/vaccine/recombinant-huaiyangshan-virus-nucleocapsid-protein-aa-1-252-his-6...